1. Home
  2. TLSA vs ASMB Comparison

TLSA vs ASMB Comparison

Compare TLSA & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • ASMB
  • Stock Information
  • Founded
  • TLSA 2013
  • ASMB 2005
  • Country
  • TLSA United Kingdom
  • ASMB United States
  • Employees
  • TLSA N/A
  • ASMB N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLSA Health Care
  • ASMB Health Care
  • Exchange
  • TLSA Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • TLSA 87.8M
  • ASMB 84.5M
  • IPO Year
  • TLSA 2000
  • ASMB 2010
  • Fundamental
  • Price
  • TLSA $0.79
  • ASMB $13.02
  • Analyst Decision
  • TLSA
  • ASMB Buy
  • Analyst Count
  • TLSA 0
  • ASMB 2
  • Target Price
  • TLSA N/A
  • ASMB $35.00
  • AVG Volume (30 Days)
  • TLSA 1.1M
  • ASMB 22.1K
  • Earning Date
  • TLSA 02-25-2025
  • ASMB 03-27-2025
  • Dividend Yield
  • TLSA N/A
  • ASMB N/A
  • EPS Growth
  • TLSA N/A
  • ASMB N/A
  • EPS
  • TLSA N/A
  • ASMB N/A
  • Revenue
  • TLSA N/A
  • ASMB $28,326,000.00
  • Revenue This Year
  • TLSA N/A
  • ASMB $282.16
  • Revenue Next Year
  • TLSA N/A
  • ASMB N/A
  • P/E Ratio
  • TLSA N/A
  • ASMB N/A
  • Revenue Growth
  • TLSA N/A
  • ASMB N/A
  • 52 Week Low
  • TLSA $0.41
  • ASMB $11.05
  • 52 Week High
  • TLSA $1.74
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 56.56
  • ASMB 40.89
  • Support Level
  • TLSA $0.65
  • ASMB $12.10
  • Resistance Level
  • TLSA $0.70
  • ASMB $14.25
  • Average True Range (ATR)
  • TLSA 0.05
  • ASMB 0.60
  • MACD
  • TLSA 0.01
  • ASMB -0.10
  • Stochastic Oscillator
  • TLSA 100.00
  • ASMB 35.11

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: